Trial intelligence / Profile preview

Acitretin in Nail Psoriasis

NCT00723437Phase 4Completed

Sponsor
Istituti Fisioterapici Ospitalieri
Start
Jan 2005
Primary completion
Jan 2007
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of acitretin in nail psoriasis, sponsored by Istituti Fisioterapici Ospitalieri. Primary endpoint: Nail Psoriasis Severity Index at 6 months. Started Jan 2005; status: completed.

02

Drugs

acitretin
03

Conditions

nail psoriasis

Beyond the preview

Go deeper on NCT00723437.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00723437.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call